Abstract
Background: Fermentation of lactose in milk by bacteria and yeasts naturally present in kefir grains produces a beverage that has been suggested to have cardiovascular benefits. This systematic review and meta-analysis of randomized controlled trials (RCTs) aimed to evaluate the effects of this kefir beverage on cardiometabolic risk factors.
Methods: Literature search utilised PubMed, Scopus, ISI Web of Science, and Google Scholar for articles published from inception until June 2021. Cardiometabolic risk indices extracted included insulin and insulin resistance (HOMA_IR), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting blood sugar (FBS), haemoglobin A1c (HbA1c) and body weight (BW). In total, six RCTs (314 subjects) were selected for the meta-analysis. Inverse-variance weighted mean difference (WMD) with a 95% confidence interval (CI) was calculated for the mean changes in TC, TG, HDL-C, LDL-C, FBS, HbA1c and BW compared to baseline. A random effects model was used to estimate the pooled WMD.
Results: Kefir intake significantly reduced fasting insulin (WMD: -3.69 micro-IU/mL,95% CI: -6.30 to -1.07, p = 0.006, I2 = 0.0%) and HOMA-IR (WMD: -2.56, 95% CI: -3.82 to -1.30, p<0.001, I2 = 19.4%). No effect on TC (p = 0.088), TG (p = 0.824), HDL-C (p = 0.491), LDL-C (p = 0.910), FBS (p = 0.267), HbA1c (p = 0.339) or body weight (p = 0.439) were found for kefir treatment.
Conclusion: Kefir has a beneficial effect in decreasing insulin resistance; however, no effect was seen on BW, FBS, HbA1C, and lipid profile.
[1]
Toscano M, De Grandi R, Pastorelli L, Vecchi M, Drago LJD, Disease L. A consumer’s guide for probiotics: 10 golden rules for a correct use. Dig Liver Dis 2017; 49(11): 1177-84.
[http://dx.doi.org/10.1016/j.dld.2017.07.011]
[http://dx.doi.org/10.1016/j.dld.2017.07.011]
[2]
Gille D, Schmid A, Walther B, Vergères GJN. Fermented food and non-communicable chronic diseases: A review. Nutrients 2018; 10(4): 448.
[http://dx.doi.org/10.3390/nu10040448]
[http://dx.doi.org/10.3390/nu10040448]
[3]
Ahmed Z, Wang Y, Ahmad A, Khan ST, Nisa M, Ahmad H, et al. Kefir and health: a contemporary perspective. Crit Rev Food Sci Nutr 2013; 53(5): 422-34.
[http://dx.doi.org/10.1080/10408398.2010.540360]
[http://dx.doi.org/10.1080/10408398.2010.540360]
[4]
Otles S. Kefir: A probiotic dairy-composition, nutritional and therapeutic aspects. Pakistan Journal of Nutrition 2003; 2(2): 54-9.
[http://dx.doi.org/10.3923/pjn.2003.54.59]
[http://dx.doi.org/10.3923/pjn.2003.54.59]
[5]
Marco ML, Heeney D, Binda S, Cifelli CJ, Cotter PD, Foligné B. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol 2017; 44: 94-102.
[http://dx.doi.org/10.1016/j.copbio.2016.11.010]
[http://dx.doi.org/10.1016/j.copbio.2016.11.010]
[6]
Tang WW, Kitai T. Gut microbiota in cardiovascular health and disease. Circ Res 2017; 120: 7-1196.: 1183-96.
[http://dx.doi.org/10.1161/CIRCRESAHA.117.309715]
[http://dx.doi.org/10.1161/CIRCRESAHA.117.309715]
[7]
Munoz-Garach A, Diaz-Perdigones C. Gut microbiota and type 2 diabetes mellitus. 2016; 63(10): 560-8.
[8]
Companys J, Pedret A, Valls RM, Sola R. Fermented dairy foods rich in probiotics and cardiometabolic risk factors: A narrative review from prospective cohort studies. Crit Rev Food Sci Nutr 2021; 61(12): 1966-75.
[http://dx.doi.org/10.1080/10408398.2020.1768045]
[http://dx.doi.org/10.1080/10408398.2020.1768045]
[9]
Mousavi SN, Saboori S, Asbaghi O. Effect of daily probiotic yogurt consumption on inflammation: A systematic review and meta-analysis of randomized Controlled Clinical trials. Obes Med 2020; 18: 100221.
[http://dx.doi.org/10.1016/j.obmed.2020.100221]
[http://dx.doi.org/10.1016/j.obmed.2020.100221]
[10]
Companys J, Pla-Pagà L, Calderón-Pérez L, et al. Fermented dairy products, probiotic supplementation, and cardiometabolic diseases: A systematic review and meta-analysis. Adv Nutr 2020; 11(4): 834-63.
[http://dx.doi.org/10.1093/advances/nmaa030]
[http://dx.doi.org/10.1093/advances/nmaa030]
[11]
Guo J, Astrup A, Lovegrove JA, Gijsbers L, Givens DI, Soedamah-Muthu SS. Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: Dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol 2017; 32(4): 269-87.
[12]
Linda CT. Fermented dairy food and CVD risk. Br J Nutr 2015; 113(S2): S131-5.
[http://dx.doi.org/10.1017/S0007114514002359]
[http://dx.doi.org/10.1017/S0007114514002359]
[13]
Thushara RM, Gangadaran S, Solati Z, Moghadasian MHJF. Cardiovascular benefits of probiotics: A review of experimental and clinical studies. Food Funct 2016; 7(2): 632-42.
[http://dx.doi.org/10.1039/c5fo01190f]
[http://dx.doi.org/10.1039/c5fo01190f]
[14]
Guzel-Seydim ZB, Kok-Tas T, Greene AK. Functional properties of kefir. Crit Rev Food Sci Nutr 2011; 51(3): 261-8.
[http://dx.doi.org/10.1080/10408390903579029]
[http://dx.doi.org/10.1080/10408390903579029]
[15]
Rondanelli M, Faliva MA, Perna S, Giacosa A, Peroni G. Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. Gut Microbes 2017; 8(6): 521-43.
[http://dx.doi.org/10.1080/19490976.2017.1345414]
[http://dx.doi.org/10.1080/19490976.2017.1345414]
[16]
Fathi Y, Ghodrati N, Zibaeenezhad M-J. Kefir drink causes a significant yet similar improvement in serum lipid profile, compared with low-fat milk, in a dairy-rich diet in overweight or obese premenopausal women: A randomized controlled trial. J Clin Lipidol 2017; 11(1): 136-46.
[http://dx.doi.org/10.1016/j.jacl.2016.10.016]
[http://dx.doi.org/10.1016/j.jacl.2016.10.016]
[17]
Bellikci-Koyu E, Sarer-Yurekli BP, Akyon Y, et al. Effects of regular kefir consumption on gut microbiota in patients with metabolic syndrome: A parallel-group, randomized, controlled study. Nutrients 2019; 11(9): 2089.
[http://dx.doi.org/10.3390/nu11092089]
[http://dx.doi.org/10.3390/nu11092089]
[18]
Alihosseini N, Moahboob S, Farrin N, Mobasseri M, Taghizadeh A, Ostadrahimi AJAE. Effect of probiotic fermented milk (kefir) on serum level of insulin and homocysteine in type 2 diabetes patients. Acta Endocrinol (Bucur) 2017; 13(4): 431-6.
[http://dx.doi.org/10.4183/aeb.2017.431] [PMID: 31149212]
[http://dx.doi.org/10.4183/aeb.2017.431] [PMID: 31149212]
[19]
Ostadrahimi A, Taghizadeh A, Mobasseri M, Farrin N, Payahoo L, Gheshlaghi ZB. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Iran J Public Health 2015; 44(2): 228.
[20]
Pražnikar ZJ, Kenig S, Vardjan T, Bizjak MČ. Effects of kefir or milk supplementation on zonulin in overweight subjects. J Dairy Sci 2020; 103(5): 3961-70.
[http://dx.doi.org/10.3168/jds.2019-17696]
[http://dx.doi.org/10.3168/jds.2019-17696]
[21]
St-Onge M-P, Farnworth ER, Savard T, Chabot D, Mafu A, Jones PJJBC. Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: A randomized controlled trial [ISRCTN10820810]. BMC Complement Altern Med 2002; 2(1): 1-7.
[http://dx.doi.org/10.1186/1472-6882-2-1]
[http://dx.doi.org/10.1186/1472-6882-2-1]
[22]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 2009; 151(4): 264-9.
[http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135] [PMID: 19622511]
[http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135] [PMID: 19622511]
[23]
Higgins JP. Cochrane handbook for systematic reviews of interventions version 5.0. 1. The Cochrane Collaboration. 2008. Available from: http://www cochrane-handbookorg.
[24]
Avicenna. The Canon of Medicine (Al-Qanon fi al-Tibb). al-Din IS (editor). Lebanon: Alamy Le- Al-Matbooat institute; 2005.
[25]
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-60.
[http://dx.doi.org/10.1136/bmj.327.7414.557] [PMID: 12958120]
[http://dx.doi.org/10.1136/bmj.327.7414.557] [PMID: 12958120]
[26]
Abd-Alwahab WI, Al-Dulaimi FK. Effects of kefir as a probiotic on total lipid profile and activity of aspartate amino transferase and alanine amino transferase in serum of human. Biochem Cell Arch 2018; 18: 411-4.
[27]
Bashiti TA, Zabut BM. Effect of probiotic fermented milk (Kefir) on some blood biochemical parameters among newly diagnosed type 2 diabetic adult males in Gaza governorate. Curr Res Nutr Food Sci 2019; 7(2)
[28]
Fathi Y, Faghih S, Zibaeenezhad MJ, Tabatabaei SHR. Kefir drink leads to a similar weight loss, compared with milk, in a dairy-rich non-energy-restricted diet in overweight or obese premenopausal women: A randomized controlled trial. Eur J Nutr 2016; 55(1): 295-304.
[http://dx.doi.org/10.1007/s00394-015-0846-9] [PMID: 25648739]
[http://dx.doi.org/10.1007/s00394-015-0846-9] [PMID: 25648739]
[29]
Gezginc Y, Maranci C. Effect of fermented food consumption on biochemical parameters and adipokines levels. Prog Nutr 2018; 20(4): 642-7.
[30]
Kullisaar T, Shepetova J, Zilmer K, Songisepp E, Rehema A, Mikelsaar M. An antioxidant probiotic reduces postprandial lipemia and oxidative stress. Cent Eur J Biol 2011; 6(1): 32-40.
[31]
Mikelsaar M, Sepp E, Štšepetova J, et al. Regulation of plasma lipid profile by lactobacillus fermentum (probiotic strain ME-3 DSM14241) in a randomised controlled trial of clinically healthy adults. BMC Nutr 2015; 1(1): 27.
[http://dx.doi.org/10.1186/s40795-015-0020-z]
[http://dx.doi.org/10.1186/s40795-015-0020-z]
[32]
Sudha MR, Chauhan P, Dixit K, Babu S, Jamil K. Probiotics as complementary therapy for hypercholesterolemia. Biol Med (Aligarh) 2009; 1(4): 1-13.
[33]
Fuentes MC, Lajo T, Carrión JM, Cuñé J. Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults. Br J Nutr 2013; 109(10): 1866-72.
[http://dx.doi.org/10.1017/S000711451200373X] [PMID: 23017585]
[http://dx.doi.org/10.1017/S000711451200373X] [PMID: 23017585]
[34]
Motawee M, ElBehairy S, El-Sisi SF, Abd El-All S. Effect of some probiotic strains on lipid metabolism. Vet Med J Giza 2007; 55(3): 763.
[35]
Kießling G, Schneider J, Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 2002; 56(9): 843-9.
[http://dx.doi.org/10.1038/sj.ejcn.1601399] [PMID: 12209372]
[http://dx.doi.org/10.1038/sj.ejcn.1601399] [PMID: 12209372]
[36]
Rosa DD, Grześkowiak ŁM, Ferreira CLLF, et al. Kefir reduces insulin resistance and inflammatory cytokine expression in an animal model of metabolic syndrome. Food Funct 2016; 7(8): 3390-401.
[http://dx.doi.org/10.1039/C6FO00339G] [PMID: 27384318]
[http://dx.doi.org/10.1039/C6FO00339G] [PMID: 27384318]
[37]
Nikbakht E, Khalesi S, Singh I, Williams LT, West NP, Colson N. Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials. Eur J Nutr 2018; 57(1): 95-106.
[http://dx.doi.org/10.1007/s00394-016-1300-3] [PMID: 27590729]
[http://dx.doi.org/10.1007/s00394-016-1300-3] [PMID: 27590729]
[38]
Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50(11): 2374-83.
[http://dx.doi.org/10.1007/s00125-007-0791-0] [PMID: 17823788]
[http://dx.doi.org/10.1007/s00125-007-0791-0] [PMID: 17823788]
[39]
Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27(3): 813-23.
[http://dx.doi.org/10.2337/diacare.27.3.813] [PMID: 14988310]
[http://dx.doi.org/10.2337/diacare.27.3.813] [PMID: 14988310]
[40]
Andreasen AS, Larsen N, Pedersen-Skovsgaard T, et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 2010; 104(12): 1831-8.
[http://dx.doi.org/10.1017/S0007114510002874] [PMID: 20815975]
[http://dx.doi.org/10.1017/S0007114510002874] [PMID: 20815975]
[41]
Chiu YH, Lu YC, Ou CC, et al. Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells. BMC Microbiol 2013; 13(1): 190.
[http://dx.doi.org/10.1186/1471-2180-13-190] [PMID: 23937116]
[http://dx.doi.org/10.1186/1471-2180-13-190] [PMID: 23937116]
[42]
Calcinaro F, Dionisi S, Marinaro M, et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005; 48(8): 1565-75.
[http://dx.doi.org/10.1007/s00125-005-1831-2] [PMID: 15986236]
[http://dx.doi.org/10.1007/s00125-005-1831-2] [PMID: 15986236]
[43]
Mariush T, Ismail S. Clinical effects of probiotic supplementation on type-2 diabetic Iraqi patients associated with dyslipidemia. J Physiol Pharmacol Adv 2013; 3(9): 239-46.
[http://dx.doi.org/10.5455/jppa.20130827045920]
[http://dx.doi.org/10.5455/jppa.20130827045920]
[44]
Gomes AC, Bueno AA, de Souza RGM, Mota JF. Gut microbiota, probiotics and diabetes. Nutr J 2014; 13(1): 60.
[http://dx.doi.org/10.1186/1475-2891-13-60] [PMID: 24939063]
[http://dx.doi.org/10.1186/1475-2891-13-60] [PMID: 24939063]
[45]
Judiono J, Hadisaputro S, Indranila KS, et al. Effects of clear kefir on biomolecular aspects of glycemic status of type 2 diabetes mellitus (T2DM) Patients in Bandung, West Java [Study on Human Blood Glucose, c Peptide and Insulin]. Funct Food Health Dis 2014; 4(8): 340-8.
[http://dx.doi.org/10.31989/ffhd.v4i8.145]
[http://dx.doi.org/10.31989/ffhd.v4i8.145]
[46]
Merenstein DJ, Foster J, D’Amico F. A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study. Arch Pediatr Adolesc Med 2009; 163(8): 750-4.
[http://dx.doi.org/10.1001/archpediatrics.2009.119] [PMID: 19652108]
[http://dx.doi.org/10.1001/archpediatrics.2009.119] [PMID: 19652108]
